Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03805750 · ClinicalTrials.gov registry record · Phase 1
Trial of Cannabis for Essential Tremor
A Phase 1 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT03805750 is a Phase 1 study that has completed, run by University of California, San Diego. The registered enrollment target is 7 participants.
The verdict
NCT03805750, a Phase 1 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a pilot trial to evaluate the safety and efficacy of a combined oral formulation of THC and CBD in patients with Essential Tremor.
Interventions
- DRUG Placebo oral capsule
- DRUG CBD/THC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-01-22 |
| Est. Completion | 2020-11-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03805750
The ClinicalTrials.gov registry entry for NCT03805750 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT03805750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03805750 about?
NCT03805750 is a clinical study titled "Trial of Cannabis for Essential Tremor". This is a pilot trial to evaluate the safety and efficacy of a combined oral formulation of THC and CBD in patients with Essential Tremor.
What is the current status of trial NCT03805750?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2019-01-22. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT03805750?
The interventions under investigation include: Placebo oral capsule (DRUG), CBD/THC (DRUG).
Who is sponsoring clinical trial NCT03805750?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.